APA (7th ed.) Citation

Pink, D., Andreou, D., Bauer, S., Brodowicz, T., Kasper, B., Reichardt, P., . . . Hohenberger, P. (2021). Treatment of angiosarcoma with pazopanib and paclitaxel: Results of the EVA (Evaluation of Votrient® in Angiosarcoma) phase II trial of the German Interdisciplinary Sarcoma Group (GISG-06). Cancers, 13(6), . https://doi.org/10.3390/cancers13061223

Chicago Style (17th ed.) Citation

Pink, Daniel, et al. "Treatment of Angiosarcoma with Pazopanib and Paclitaxel: Results of the EVA (Evaluation of Votrient® in Angiosarcoma) Phase II Trial of the German Interdisciplinary Sarcoma Group (GISG-06)." Cancers 13, no. 6 (2021). https://doi.org/10.3390/cancers13061223.

MLA (9th ed.) Citation

Pink, Daniel, et al. "Treatment of Angiosarcoma with Pazopanib and Paclitaxel: Results of the EVA (Evaluation of Votrient® in Angiosarcoma) Phase II Trial of the German Interdisciplinary Sarcoma Group (GISG-06)." Cancers, vol. 13, no. 6, 2021, https://doi.org/10.3390/cancers13061223.